🔴 Damora Therapeutics is trading 10.17% down today as oil and Treasury yields weigh on markets

Damora Therapeutics is trading 10.17% down at $20.13 on September 23, 2026, amid broad market weakness.

• The Nasdaq Composite and S&P 500 are both down more than 0.5%, while rising crude oil prices and Treasury yields are weighing on risk assets.
• No new company-specific announcement was identified for September 23; the latest listed release concerns August inducement grants. The decline therefore appears primarily global rather than company-specific.